GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease
GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
pharmaceutical investing GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease
Spartan Metals' Exploration Program Confirms Tungsten Skarn Discoveries at past Producing Mine at Eagle Project, Nevada
Star Copper Extends Copper Creek Drill Hole Beyond Planned Depth After Intersecting Mineralized System
